Detalhe da pesquisa
1.
SARS-CoV-2 infection in patients with chronic lymphocytic leukemia: The Italian Hematology Alliance on COVID-19 cohort.
Hematol Oncol
; 41(1): 128-138, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36265128
2.
Neutralizing monoclonal antibodies in haematological patients paucisymptomatic for COVID-19: The GIMEMA EMATO-0321 study.
Br J Haematol
; 199(1): 54-60, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35906881
3.
Lack of efficacy of convalescent plasma in COVID-19 patients with concomitant hematological malignancies: An Italian retrospective study.
Hematol Oncol
; 40(5): 857-863, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35932208
4.
Secondary infections worsen the outcome of COVID-19 in patients with hematological malignancies: A report from the ITA-HEMA-COV.
Hematol Oncol
; 40(5): 846-856, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35854643
5.
COVID-19 elicits an impaired antibody response against SARS-CoV-2 in patients with haematological malignancies.
Br J Haematol
; 195(3): 371-377, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34272724
6.
Early CAR- CD4+ T-lymphocytes recovery following CAR-T cell infusion: A worse outcome in diffuse large B cell lymphoma.
EJHaem
; 5(2): 360-368, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38633118
7.
Prompt detection of L-asparaginase inactivation is crucial to optimize treatment efficacy also in aggressive lymphomas.
Hematol Oncol
; 36(2): 498-499, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29052244
8.
A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study.
Blood Adv
; 6(1): 327-338, 2022 01 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34644385
9.
Dexamethasone, oxaliplatin and cytarabine (R-DHAOx) as salvage and stem cells mobilizing therapy in relapsed/refractory diffuse large B cell lymphomas.
Leuk Lymphoma
; 61(1): 84-90, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31480933